头颈癌幸存者经济毒性的客观与主观评估
该横断面分析纳入71例有头颈癌特异性自付费用理赔数据的幸存者,完成COST和FDQ问卷调查。更差的COST评分与调查时较低收入、诊断后收入损失及年自付费用占收入比例较高显著相关,FDQ结果类似。经济毒性与社会经济特征相关,有助于开发治疗前筛查工具识别高危个体并早期干预。
要点
- 头颈癌幸存者经济毒性与低收入、收入损失及高自付费用占比相关。
- COST和FDQ两种主观经济毒性工具结果一致。
- 可基于社会经济特征开发治疗前筛查工具识别高危患者。
核心结论
- 经济毒性与特定社会经济特征相关,理解这些特征有助于开发治疗前筛查工具以识别高危个体并早期干预。
研究设计与样本
- 横断面分析,纳入71例有头颈癌特异性自付费用理赔数据的幸存者,完成COST和FDQ问卷调查。
主要发现
- 更差的COST评分与调查时较低收入显著相关(系数=3.79;95%CI 2.63-4.95;p<0.001)。
- 更差的COST评分与诊断后收入损失显著相关(系数=6.03;95%CI 0.53-11.52;p=0.032)。
- 更差的COST评分与年自付费用占收入比例较高显著相关(log10(年自付费用:调查时收入)系数=-5.66;95%CI -10.28至-1.04;p=0.017)。
- FDQ结果与COST类似。
临床怎么用
- 临床可关注头颈癌幸存者的收入水平、诊断后收入损失及自付费用占收入比例,以识别经济毒性高危个体。
- 可基于社会经济特征开发治疗前筛查工具,在幸存者轨迹中早期干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is documented regarding objective financial metrics and their impact on subjective financial toxicity in head and neck cancer (HNC) survivors. METHODS: In a cross-sectional analysis, 71 survivors with available claims data for HNC-specific out-of-pocket expenses (OOPE) completed a survey including patient-reported, subjective financial toxicity outcome tools: the Comprehensive Score for financial Toxicity (COST) and the Financial Distress Questionnaire (FDQ). RESULTS: Worse COST scores were significantly associated with lower earnings at survey administration (coefficient = 3.79; 95% CI 2.63-4.95; p < 0.001); loss of earnings after diagnosis (coefficient = 6.03; 95% CI 0.53-11.52; p = 0.032); and greater annual OOPE as a proportion of earnings [log10(Annual OOPE:Earnings at survey): coefficient = -5.66; 95% CI -10.28 to -1.04; p = 0.017]. Similar results were found with FDQ. CONCLUSION: Financial toxicity is associated with particular socioeconomic characteristics which, if understood, would assist the development of pre-treatment screening tools to detect at-risk individuals and intervene early in the HNC cancer survivorship trajectory.
引用
- Baddour K, Fadel M, Zhao M, et al. The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors. Head Neck. 2021. PMID: 34235804. doi:10.1002/hed.26801
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。